Add three genetic disorders to newborn screening tests

Last Updated July 27, 2026 44:19:01:04. Required tests. In addition to the metabolic disorder tests required in SDCL
34-24-18, a designated laboratory shall screen any infant born in this state for the following
newborn screening disorders:
(1) Hemoglobinopathies;
(2) Biotinidase deficiency;
(3) Classical congenital adrenal hyperplasia;
(4) Fatty acid oxidation disorders;
(5) Amino acid disorders;
(6) Organic acid disorders;
(7) Cystic fibrosis;
(8) Severe combined immunodeficiency disorder;
(9) Spinal muscular atrophy;
(10) Glycogen storage disease type II or Pompe disease; and
(11) X-linked adrenoleukodystrophy (X-ALD);
(12) Duchenne Muscular Dystrophy (DMD);
(13) Mucopolysaccharidosis Type I (MPS I); and
(14) Mucopolysaccharidosis Type II (MPS II).
Each physician, nurse practitioner, physician assistant, certified nurse midwife, or certified
professional midwife providing childbirth services shall perform a newborn hearing screening on
any infant the provider or midwife delivers in this state.
Source: 31 SDR 164, effective May 9, 2005; 33 SDR 180, effective May 7, 2007; 42 SDR
14, effective August 10, 2015; 47 SDR 137, effective June 28, 2021; 49 SDR 16, effective
September 1, 2022; 50 SDR 139, effective June 2, 2024.
Last Updated July 27, 2026 General Authority: SDCL 34-24-25.
Law Implemented: SDCL 34-24-22.